최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.32 no.3, 2022년, pp.241 - 248
이정아 (창원대학교 생명보건학부) , 김동완 (창원대학교 생명보건학부)
NF-κB acts as a critical transcription factor in inflammation and innate immunity, and it is also closely involved in cell survival and tumorigenesis via induction of anti-apoptotic genes. In these processes, NF-κB cooperates with multiple other signaling molecules and pathways, and al...
Bai, L., Xu, S., Chen, W., Li, Z., Wang, X., Tang, H. and Lin, Y. 2011. Blocking NF-κB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death. Apoptosis 16, 45-54.
Baldwin, A. S. Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
Chariot, A. 2009. The NF-kappaB-independent functions of IKK subunits in immunity and cancer. Trends Cell Biol. 19, 404-413.
Dai, S., Hirayama, T., Abbas, S. and Abu Amer, Y. 2004. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J. Biol. Chem. 279, 37219-37222.
DiDonato, J. A., Mercurio, F. and Karin, M. 2012. NF-κB and the link between inflammation and cancer. Immunol. Rev. 246, 379-400.
Hariharan, A., Hakeem, A. R., Radhakrishnan, S., Reddy, M. S. and Rela, M. 2021. The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients. Inflammopharmacology 29, 91-100.
Hoesel, B. and Schmid, J. A. 2013. The complexity of NF-κB signaling in inflammation and cancer. Mol. Cancer 12, 86.
Hoter, A., El-Sabban, M. E. and Naim, H. Y. 2018. The HSP90 family: structure, regulation, function, and implications in health and disease. Int. J. Mol. Sci. 19, 2560.
Kwon, W. J., Kim, S. H., Park, Y. O., Cho, M., Kang, C. D., Lee, G., An, W. G., Joo, W. H. and Kim, D. W. 2004. IKKgamma inhibits activation of NF-kappaB by NIK. Mol. Cells 18, 200-206.
Lawrence, T. and Fong, C. 2010. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int. J. Biochem. Cell Biol. 42, 519-523.
Li, X. H., Fang, X. and Gaynor, R. B. 2001. Role of IKKgamma/nemo in assembly of the Ikappa B kinase complex. J. Biol. Chem. 276, 4494-4500.
Liu, F., Xia, Y., Parker, A. S. and Verma, I. M. 2012. IKK biology. Immunol. Rev. 246, 239-253.
Mauro, C., Pacifico, F., Lavorgna, A., Mellone, S., Iannetti, A., Acquaviva, R., Formisano, S., Vito, P. and Leonardi, A. 2006. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB. J. Biol. Chem. 281, 18482-18488.
Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J., Young, D. B., Barbosa, M., Mann, M., Manning, A. and Rao, A. 1997. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278, 860-866.
Mitchell, S., Vargas, J. and Hoffmann, A. 2016. Signaling via the NFκB system. Wiley Interdiscip. Rev. Syst. Biol. Med. 8, 227-241.
Oeckinghaus, A. and Ghosh, S. 2009. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect. Biol. 1, a000034.
Ono, K., Sogawa, C., Kawai, H., Tran, M. T., Taha, E. A., Lu, Y., Oo M. W., Okusha, Y., Okamura, H., Ibaragi, S., Takigawa, M., Kozaki, K. I., Nagatsuka, H., Sasaki, A., Okamoto, K., Calderwood, S. K. and Eguchi, T. 2020. Triple knockdown of CDC37, HSP90-alpha and HSP90-beta diminishes extracellular vesicles-driven malignancy events and macrophage M2 polarization in oral cancer. J. Extracell. Vesicles 9, 1769373.
Pflug, K. M. and Sitcheran, R. 2020. Targeting NF-κB-Inducing Kinase (NIK) in immunity, inflammation, and cancer. Int. J. Mol. Sci. 21, 8470.
Picard, D. 2015. Hsp90 interactors. http://www.picard.ch/downloads/Hsp90interactors.pdf (last accessed on Dec. 21, 2015).
Rapino, F., Abhari, B. A., Jung, M. and Fulda, S. 2015. NIK is required for NF-κB-mediated induction of BAG3 upon inhibition of constitutive protein degradation pathways. Cell Death Dis. 6, e1692.
Rasmi, R. R., Sakthivel, K. M. and Guruvayoorappan, C. 2020. NF-κB inhibitors in treatment and prevention of lung cancer. Biomed. Pharmacother. 130, 110569.
Tabata, M., Tsubaki, M., Takeda, T., Tateishi, K., Maekawa, S., Tsurushima, K., Imano, M., Satou, T., Ishizaka, T. and Nishida, S. 2020. Inhibition of HSP90 overcomes melphalan resistance through downregulation of Src in multiple myeloma cells. Clin. Exp. Med. 20, 63-71.
Thangjam, G. S., Birmpas, C., Barabutis, N., Gregory, B. W., Clemens, M. A., Newton, J. R., Fulton, D. and Catravas, J. D. 2016. Hsp90 inhibition suppresses NF-κB transcriptional activation via Sirt-2 in human lung microvascular endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 310, L964-974.
Thangjam, G. S., Dimitropoulou, C., Joshi A. D., Barabutis, N., Shaw, M. C., Kovalenkov, Y., Wallace, C. M., Fulton, D. J., Patel, V. and Catravas, J. D. 2014. Novel mechanism of attenuation of LPS-induced NF-κB activation by the heat shock protein 90 inhibitor, 17-N-allylamino-17-demethoxygeldanamycin, in human lung microvascular endothelial cells. Am. J. Respir. Cell Mol. Biol. 50, 942-952.
Vannini, F., Kashfi, K. and Nath, N. 2015. The dual role of iNOS in cancer. Redox Biol. 6, 334-343.
Yamamoto, Y., Kim, D. W., Kwak, Y. T., Prajapati, S., Verma, U. and Gaynor, R. B. 2001. IKKgamma /NEMO facilitates the recruitment of the IkappaB proteins into the IkappaB kinase complex. J. Biol. Chem. 276, 36327-36336.
Zhang, P. C., Liu, X., Li, M. M., Ma, Y. Y., Sun, H. T., Tian, X. Y., Wang, Y., Liu, M., Fu, L. S., Wang, Y. F., Chen, H. Y. and Liu, Z. 2020. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo. Biochem. Pharmacol. 172, 113771.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.